BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02964507-completion@plaintrial.com
DTSTAMP:20261028T173606Z
DTSTART;VALUE=DATE:20210719
SUMMARY:Dose Escalation and Expansion Study of GSK525762 in Combination Wit
 h Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human E
 pidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic 
 Breast Cancer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02964507
URL:https://plaintrial.com/trial/NCT02964507
END:VEVENT
END:VCALENDAR